Constipation and intestinal neuronal dysplasia type B: a clinical follow-up study

J Pediatr Gastroenterol Nutr. 2004 Mar;38(3):308-11. doi: 10.1097/00005176-200403000-00015.

Abstract

Objective: Intestinal neuronal dysplasia type B (IND B) is one of the gastrointestinal motility disorders with a defined malformation of the parasympathetic submucous and myenteric ganglia. The clinical presentation of IND B is variable, ranging from intestinal obstruction in the neonatal period to acute or chronic constipation in childhood.

Methods: Between 1993 and 1996, 105 patients (49 females and 56 males) were treated for constipation, and in all of them an IND type B was confirmed histopathologically. Twenty-two neonates, 42 infants to 6 months of age (38% of them were premature, and 5% had additional malformations), and 41 patients to the age of 4 years were included in this study. All 105 patients had been treated conservatively. Treatment consisted of diet in all patients, cisapride in 70% of them, laxatives in 52%, and repeated anal dilatations in 12% of the patients. The mean duration of their treatment lasted from 3 months to 10 months (mean, 6 months).

Results: The clinical follow-up 5 to 9 years later in 89 of the 108 (85%) patients showed daily defecation in 80% of them and every second day in 14% of them. Only 5 (6%) patients experience recurrent constipation, which responds well to diet and laxatives.

Conclusions: In young patients, constipation related to IND B can be treated successfully by conservative treatment regimens, including diet, laxatives, and prokinetic drugs.

MeSH terms

  • Age of Onset
  • Cathartics / therapeutic use*
  • Child, Preschool
  • Cisapride / therapeutic use*
  • Constipation / drug therapy
  • Constipation / etiology*
  • Defecation / drug effects
  • Defecation / physiology
  • Female
  • Follow-Up Studies
  • Gastrointestinal Agents / therapeutic use*
  • Humans
  • Infant
  • Infant, Newborn
  • Intestinal Diseases / diet therapy
  • Intestinal Diseases / drug therapy
  • Intestinal Diseases / therapy*
  • Intestines / innervation*
  • Male
  • Myenteric Plexus / abnormalities
  • Myenteric Plexus / pathology
  • Recurrence
  • Submucous Plexus / abnormalities
  • Submucous Plexus / pathology

Substances

  • Cathartics
  • Gastrointestinal Agents
  • Cisapride